Author/Authors :
namdaroğlu, sinem izmir bozyaka eğitim ve araştırma hastanesi - hematoloji kliniği, İzmir, Turkey , medeni, şerife solmaz izmir bozyaka eğitim ve araştırma hastanesi - hematoloji kliniği, İzmir, turkey , çetintepe, tuğba izmir bozyaka eğitim ve araştırma hastanesi - hematoloji kliniği, İzmir, Turkey , namdaroğlu, ozan barış izmir bozyaka eğitim ve araştırma hastanesi - genel cerrahi kliniği, İzmir, Turkey , bilgir, oktay izmir bozyaka eğitim ve araştırma hastanesi - hematoloji kliniği, İzmir, Turkey
Abstract :
Antiphospholipid antibody syndrome (APS) is a systemic autoimmune disorder characterized by recurrent arterial or venous thrombosis, fetal loss, thrombocytopenia, neurological symptoms and presence of serum antiphospholipid antibodies (AFA). In this report,we present a young male patient with thrombocytopenia who was refractory to steroids, intravenous immunoglobulin and splenectomy but had complete response to eltrombopag treatment, FV Leiden heterozygous mutant positive, also had a history of sinüs thrombosis taking oral anticoagulant treatment has been diagnosed primary APS. Eltrombopag treatment primary antiphospholipid syndrome patient associated with refractory thrombocytopenia.
NaturalLanguageKeyword :
Eltrombopag , Primary antiphospholipid syndrome , Thrombocytopenia , Factor V Leiden
